October 17, 2011 –– USARAD.com, the United States teleradiology company, announces the launch of its WorldRad.com division, which will service and position the company in the international marketplace. WorldRad.com will extend the company’s global reach, from Europe and Asia to the Middle East, South America and more, where it anticipates a major need for its services.

October 17, 2011– GE Healthcare announced that the U.S. Food and Drug Administration (FDA) gave 510(k) clearance of an innovative technology to aid the physician in breast cancer diagnosis. GE estimates that by 2020, more than 1 million women worldwide will be examined using SenoBright, and this technology can help lead to more productive diagnosis paths for nearly 250,000 women.

At RSNA 2011, Hologic will showcase its new Trident specimen radiography system, which uses proprietary direct digital detector technology. The imaging system produces high quality images for rapid verification of tissue specimens such as breast biopsy samples.

Trident specimen radiography system

October 17, 2011 — New this year at RSNA 2011, Hologic will showcase its Fluoroscan InSight-FD Mini C-arm. The system includes a number of new features including an innovative flat panel detector that rivals standard X-ray images, greater range of motion in a more ergonomic design for ease of positioning and greater surgical access, and new image processing algorithms.

October 14, 2011 — GE Healthcare received U.S. Food and Drug Administration (FDA) clearance of the Discovery MR750w wide bore 3.0T system with GEM (Geometry Embracing Method) suite of coils.

October 14, 2011 — Merge Healthcare announced the release of the “Meaningful Use Guide for Radiology” resource written specifically for radiologists.

October 14, 2011 — A study published in the September/October issue of Radiologic Technology shows increasing the source-to-image distance for direct digital radiography (DR) pelvic examinations reduces radiation dose while maintaining image quality. RT is a journal of the American Society of Radiologic Technologists (ASRT).

October 14, 2011 — For patients with non-small cell lung cancer (NSCLC), accurate determination of lymph node status before therapy is critical to develop an individualized treatment plan. Research from the October issue of The Journal of Nuclear Medicine highlights a new way for this information to be collected—a virtual fly-through three-dimensional 18F-FDG positron emission tomography/computed tomography (FDG-PET/CT) bronchoscopy that has high diagnostic accuracy for the detection of regional lymph node metastases.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now